Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction a randomized clinical trial (2018)
- Autores:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1001/jamacardio.2018.0612
- Assuntos: SÍNDROME CORONARIANA AGUDA; ESTUDOS RANDOMIZADOS; FÁRMACOS (SISTEMA CARDIOVASCULAR); INFARTO DO MIOCÁRDIO
- Agências de fomento:
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título: Jama cardiology
- ISSN: 2380-6583
- Volume/Número/Paginação/Ano: v. 3, n. 5, p. 391-399, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
BERWANGER, Otavio e NICOLAU, Jose C. Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction a randomized clinical trial. Jama cardiology, v. 3, n. 5, p. 391-399, 2018Tradução . . Disponível em: https://doi.org/10.1001/jamacardio.2018.0612. Acesso em: 11 nov. 2024. -
APA
Berwanger, O., & Nicolau, J. C. (2018). Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction a randomized clinical trial. Jama cardiology, 3( 5), 391-399. doi:10.1001/jamacardio.2018.0612 -
NLM
Berwanger O, Nicolau JC. Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction a randomized clinical trial [Internet]. Jama cardiology. 2018 ; 3( 5): 391-399.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1001/jamacardio.2018.0612 -
Vancouver
Berwanger O, Nicolau JC. Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction a randomized clinical trial [Internet]. Jama cardiology. 2018 ; 3( 5): 391-399.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1001/jamacardio.2018.0612 - Síndrome coronariana aguda com elevação do segmento St: tratamento medicamentoso
- Isquemia miocárdica como manifestação inicial de arterite de Takaysu
- Prasugrel, ticagrelor e antagonista do receptor da trombina nas síndromes isquêmicas miocárdicas instáveis com e sem supradesnível do segmento ST
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
- Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy
- Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial
- Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome
Informações sobre o DOI: 10.1001/jamacardio.2018.0612 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
